Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Poseida Therapeutics Inc | PSTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.86 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 1.54 - 4.27 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 2.86 | USD |
Poseida Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
275.96M | 96.49M | - | 64.7M | -123.43M | -1.28 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Poseida Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PSTX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.93 | 3.11 | 2.8047 | 2.97 | 350,994 | -0.07 | -2.39% |
1 Month | 2.69 | 3.55 | 2.592 | 2.95 | 662,742 | 0.17 | 6.32% |
3 Months | 3.48 | 4.17 | 1.87 | 2.97 | 708,489 | -0.62 | -17.82% |
6 Months | 2.66 | 4.27 | 1.87 | 3.09 | 832,411 | 0.20 | 7.52% |
1 Year | 2.38 | 4.27 | 1.54 | 2.63 | 833,597 | 0.48 | 20.17% |
3 Years | 8.49 | 11.10 | 1.54 | 3.76 | 594,805 | -5.63 | -66.31% |
5 Years | 17.00 | 17.62 | 1.54 | 4.78 | 535,150 | -14.14 | -83.18% |
Poseida Therapeutics Description
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours. |